Diisopropylfluorophosphate-induced status epilepticus drives complex glial cell phenotypes in adult male mice

• Published in: Neurobiology of disease 2021-05, Vol.152, p.105276, Article 105276
• Main Authors: Maupu, Clémence, Enderlin, Julie, Igert, Alexandre, Oger, Myriam, Auvin, Stéphane, Hassan-Abdi, Rahma, Soussi-Yanicostas, Nadia, Brazzolotto, Xavier, Nachon, Florian, Dal Bo, Grégory, Dupuis, Nina
• Format: Article
• Language: English
• Subjects: Animals; Astrocyte; Cholinesterase Inhibitors - toxicity; Cognitive science; Cytokines; DFP; Environmental Sciences; Isoflurophate - toxicity; Life Sciences; Male; Mice; Microglia; Neuroglia - drug effects; Neurotoxicity Syndromes - pathology; Organophosphates; Organophosphorus; Phenotype; Sciences of the Universe; Seizure; Status Epilepticus - chemically induced
• ISSN: 0969-9961; 1095-953X
• DOI: 10.1016/j.nbd.2021.105276

Organophosphate pesticides and nerve agents (OPs), are characterized by cholinesterase inhibition. In addition to severe peripheral symptoms, high doses of OPs can lead to seizures and status epilepticus (SE). Long lasting seizure activity and subsequent neurodegeneration promote neuroinflammation leading to profound pathological alterations of the brain. The aim of this study was to characterize neuroinflammatory responses at key time points after SE induced by the OP, diisopropylfluorophosphate (DFP). Immunohistochemistry (IHC) analysis and RT-qPCR on cerebral tissue are often insufficient to identity and quantify precise neuroinflammatory alterations. To address these needs, we performed RT-qPCR quantification after whole brain magnetic-activated cell-sorting (MACS) of CD11B (microglia/infiltrated macrophages) and GLAST (astrocytes)-positive cells at 1, 4, 24 h and 3 days post-SE. In order to compare these results to those obtained by IHC, we performed, classical Iba1 (microglia/infiltrated macrophages) and GFAP (astrocytes) IHC analysis in parallel, focusing on the hippocampus, a brain region affected by seizure activity and neurodegeneration. Shortly after SE (1–4 h), an increase in pro-inflammatory (M1-like) markers and A2-specific markers, proposed as neurotrophic, were observed in CD11B and GLAST-positive isolated cells, respectively. Microglial cells successively expressed immuno-regulatory (M2b-like) and anti-inflammatory (M2a-like) at 4 h and 24 h post-SE induction. At 24 h and 3 days, A1-specific markers, proposed as neurotoxic, were increased in isolated astrocytes. Although IHC analysis presented no modification in terms of percentage of marked area and cell number at 1 and 4 h after SE, at 24 h and 3 days after SE, microglial and astrocytic activation was visible by IHC as an increase in Iba1 and GFAP-positive area and Iba1-positive cells in DFP animals when compared to the control. Our work identified sequential microglial and astrocytic phenotype activation. Although the role of each phenotype in SE cerebral outcomes requires further study, targeting specific markers at specific time point could be a beneficial strategy for DFP-induced SE treatment.